Fact CheckerSign in

NCT07073989Recruiting

Investigating the Impact of Afferent Stimulation on Proprioceptive Function in Post-Stroke Rehabilitation

Source: ClinicalTrials.gov · Last updated 20 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The objective of this study is to assess the functionality of a sensory stimulation device that uses mechanical vibrations and low-intensity electrical currents to deliver proprioceptive feedback to stroke patients regarding their movements.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
20 (estimated)
First submitted
20 Jun 2025
Start date
17 Jun 2025
Primary completion date
Sept 2025
Lead sponsor
Julio S. Lora Millán
Diseases
Stroke
NCT number
NCT07073989

What you commit to

  • Study type: Interventional
  • Planned participants: 20
  • From 17 Jun 2025 to the primary completion date, Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Acute musculoskeletal disorders.
  • Peripheral vascular diseases.
  • Acute cardiopulmonary conditions.
  • Acute neurological disorders.

Other

  • Restricted mobility of upper limb joints due to any cause.
  • Pain as a cause of impaired upper limb mobility.

Who the study is looking for

  • For healthy subjects:
    • No neurological or orthopedic conditions affecting upper limb movement.
    • No surgical interventions on the upper limbs within the past 6 months.
    • General physical condition adequate to perform the session.
    • Cognitive abilities sufficient to understand and carry out the experimental procedure.
  • For stroke survivors:
    • Ischemic or hemorrhagic stroke resulting in motor impairments in the upper limb.
    • Chronic stroke condition.
    • Subjects with sufficient cognitive abilities to follow instructions and actively participate in the therapy.
    • Mini-Mental State Examination (MMSE) score \> 24.
    • Subjects presenting hemiparesis and mild-to-moderate impairment in the upper limb (score on the Fugl-Meyer Motor Assessment for the upper limb, sections A-D, between 35 and 53 points). The maximum score on the FM scale is 66, with the following severity classifications:
  • 0-15: severe impairment
  • 16-34: moderate-to-severe impairment
  • 35-53: mild-to-moderate impairment
  • 54-66: mild impairment 6. Subjects presenting upper limb hypertonia with a score below 3 on the Modified Ashworth Scale.
    • 7\. Subjects who have signed the informed consent document to voluntarily participate in the experiments.

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Universidad Rey Juan Carlos
Coordinator of this site? Confirm its status
MóstolesSpainRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.